摘要
药物可以改善阿尔兹海默病(AD)患者的认知功能,但仍然不能完全治愈AD。中医方剂补阳还五汤常被用于治疗卒中及脑血管意外后遗症,其对患病大脑治疗的明显改善临床效果已延伸至对AD的治疗。男性患AD的风险明显低于绝经后的女性,提示AD的发生可能与雌激素水平减少有关。本文将从雌激素角度对补阳还五汤防治AD的研究进展做一综述,主要内容包括补阳还五汤治疗AD的药理作用、雌激素水平与AD的关系、补阳还五汤通过调控雌激素水平防治AD等。
There are some drugs which are used to improve the cognitive function of patients with Alzheimer’s disease(AD),but they still can not completely cure AD.Buyang Huanwu decoction,a traditional Chinese medicine prescription,is often used to treat the sequelae of stroke and cerebrovascular accidents.Its clinical effect of significantly improving the treatment of diseased brain has been extended to the application of AD.The risk of AD in men is significantly lower than that in postmenopausal women,suggesting that it may be related to the reduction of estrogen levels.This paper reviews the research progress of Buyang Huanwu decoction in the prevention and treatment of AD from the perspective of estrogen.The main contents include the pharmacological effect of Buyang Huanwu decoction in the treatment of AD,the relationship between estrogen level and AD,Buyang Huanwu decoction in the prevention and treatment of AD by regulating estrogen level,etc.
作者
武凤
董晓红
徐艳明
孙琪
刘彦宏
雷霞
张宁
刘斌
WU Feng;DONG Xiao-hong;XU Yan-ming;SUN Qi;LIU Yan-hong;LEI Xia;ZHANG Ning;LIU Bin(School of Basic Medicine,Heilongjiang University of Traditional Chinese Medicine,Harbin 150040,Heilongjiang Province,China;School of Pharmacy,Heilongjiang University of Traditional Chinese Medicine,Harbin 150040,Heilongjiang Province,China;Jiamusi College,Heilongjiang University of Traditional Chinese Medicine,Jiamusi 154007,Heilongjiang Province,China)
出处
《中国临床药理学杂志》
CAS
CSCD
北大核心
2022年第23期2915-2918,共4页
The Chinese Journal of Clinical Pharmacology
基金
国家自然科学基金面上基金资助项目(81673581)
黑龙江省自然科学基金资助项目(H2018058)
黑龙江中医药大学优秀创新人才支持计划基金资助项目(2018RCD19)
黑龙江省大学生创新创业基金资助项目(201910228083)
黑龙江省中医药管理局科研课题基金资助项目(ZHY202087,ZHY202088)。
关键词
阿尔兹海默病
补阳还五汤
雌激素
Alzheimer’s disease
Buyang Huanwu decoction
estrogen